Paper
0
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Authors
Stuart Connolly,Michael Ezekowitz
Salim Yusuf,John Eikelboom,Jonas Oldgren,Amit Parekh,Janice Pogue,Paul Reilly,Ellison Themeles,Jeanne Varrone,Ru Tan,Marco Alings,Denis Xavier,Jun Zhu,Rafael Díaz,Basil Lewis,Harald Darius,Christoph Bode,Campbell Joyner,Lars Wallentin,Susan Wang,Rafael Dı́az
+20 authors
,Hans‐Christoph DienerPublished
Aug 31, 2009
Show more
Save
Tip0
TipSave
Abstract
Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.